Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


18.06.2018

1 Ann Oncol
1 Anticancer Res
1 Cancer Lett
1 Clin Cancer Res
2 Eur J Surg Oncol
4 Gastroenterology
1 Int J Colorectal Dis
2 Int J Oncol
3 Oncogene
2 Oncol Rep
1 PLoS Comput Biol
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. CREMOLINI C, Antoniotti C, Lonardi S, Bergamo F, et al
    Primary Tumor Sidedness and Benefit from FOLFOXIRI plus Bevacizumab as Initial Therapy for Metastatic Colorectal Cancer.
    Ann Oncol. 2018 Apr 20. pii: 4979452. doi: 10.1093.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. ANGELOU A, Andreatos N, Antoniou E, Zacharioudaki A, et al
    A Novel Modification of the AOM/DSS Model for Inducing Intestinal Adenomas in Mice.
    Anticancer Res. 2018;38:3467-3470.
    PubMed     Text format     Abstract available


    Cancer Lett

  3. HONG Y, Liew SC, Thean LF, Tang CL, et al
    Human colorectal cancer initiation is bidirectional, and cell growth, metabolic genes and transporter genes are early drivers of tumorigenesis.
    Cancer Lett. 2018;431:213-218.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  4. KIM TW, Peeters M, Thomas AL, Gibbs P, et al
    Impact of Emergent Circulating Tumor DNA RAS Mutation in Panitumumab-Treated Chemoresistant Metastatic Colorectal Cancer.
    Clin Cancer Res. 2018 Jun 13. pii: 1078-0432.CCR-17-3377.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  5. VALLANCE AE, van der Meulen J, Kuryba A, Braun M, et al
    Socioeconomic differences in selection for liver resection in metastatic colorectal cancer and the impact on survival.
    Eur J Surg Oncol. 2018 May 26. pii: S0748-7983(18)31078.
    PubMed     Text format     Abstract available

  6. TRAUTMANN F, Reissfelder C, Pecqueux M, Weitz J, et al
    Evidence-based quality standards improve prognosis in colon cancer care.
    Eur J Surg Oncol. 2018 May 17. pii: S0748-7983(18)31067.
    PubMed     Text format     Abstract available


    Gastroenterology

  7. NGUYEN AD, Ahmed A, Jain R
    A Peculiar Cause of Rectal Prolapse.
    Gastroenterology. 2018;154:1586-1587.
    PubMed     Text format    

  8. BACKES Y, Elias SG, Groen JN, Schwartz MP, et al
    Histologic Factors Associated With Need for Surgery in Patients With Pedunculated T1 Colorectal Carcinomas.
    Gastroenterology. 2018;154:1647-1659.
    PubMed     Text format     Abstract available

  9. VLEUGELS JLA, Dijkgraaf MGW, Hazewinkel Y, Wanders LK, et al
    Effects of Training and Feedback on Accuracy of Predicting Rectosigmoid Neoplastic Lesions and Selection of Surveillance Intervals by Endoscopists Performing Optical Diagnosis of Diminutive Polyps.
    Gastroenterology. 2018;154:1682-1693.
    PubMed     Text format     Abstract available

  10. DEKKER E, Rex DK
    Advances in CRC Prevention: Screening and Surveillance.
    Gastroenterology. 2018;154:1970-1984.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  11. ACKERMANN CJ, Guller U, Jochum W, Schmied BM, et al
    The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis.
    Int J Colorectal Dis. 2018 Jun 7. pii: 10.1007/s00384-018-3096.
    PubMed     Text format     Abstract available


    Int J Oncol

  12. LEE JY, Kim MS, Ju JE, Lee MS, et al
    Simvastatin enhances the radiosensitivity of p53deficient cells via inhibition of mouse double minute 2 homolog.
    Int J Oncol. 2018;52:211-218.
    PubMed     Text format     Abstract available

  13. CHEN J, Gong C, Mao H, Li Z, et al
    E2F1/SP3/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells.
    Int J Oncol. 2018 Jun 5. doi: 10.3892/ijo.2018.4429.
    PubMed     Text format     Abstract available


    Oncogene

  14. ZENG K, Chen X, Hu X, Liu X, et al
    LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
    Oncogene. 2018 Jun 13. pii: 10.1038/s41388-018-0352.
    PubMed     Text format     Abstract available

  15. LEE H, Kim N, Yoo YJ, Kim H, et al
    beta-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer.
    Oncogene. 2018 Jun 12. pii: 10.1038/s41388-018-0362.
    PubMed     Text format     Abstract available

  16. LIU J, Zhang Z, Li X, Chen J, et al
    Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expression.
    Oncogene. 2018 Jun 8. pii: 10.1038/s41388-018-0355.
    PubMed     Text format     Abstract available


    Oncol Rep

  17. GUO Y, Wang M, Jia X, Zhu H, et al
    Wnt signaling pathway upregulates DNMT1 to trigger NHERF1 promoter hypermethylation in colon cancer.
    Oncol Rep. 2018 Jun 14. doi: 10.3892/or.2018.6494.
    PubMed     Text format     Abstract available

  18. ZHANG Y, Wang S, Qian W, Ji D, et al
    uc.338 targets p21 and cyclin D1 via PI3K/AKT pathway activation to promote cell proliferation in colorectal cancer.
    Oncol Rep. 2018 Jun 7. doi: 10.3892/or.2018.6480.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  19. SHIMONI Y
    Association between expression of random gene sets and survival is evident in multiple cancer types and may be explained by sub-classification.
    PLoS Comput Biol. 2018;14:e1006026.
    PubMed     Text format     Abstract available


    PLoS One

  20. YU Y, Cheng D, Parfrey P, Liu G, et al
    Two functional indel polymorphisms in the promoter region of the Brahma gene (BRM) and disease risk and progression-free survival in colorectal cancer.
    PLoS One. 2018;13:e0198873.
    PubMed     Text format     Abstract available

  21. MESSARITAKIS I, Stogiannitsi M, Koulouridi A, Sfakianaki M, et al
    Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer.
    PLoS One. 2018;13:e0197327.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  22. TANG YA, Chen YF, Bao Y, Mahara S, et al
    Hypoxic tumor microenvironment activates GLI2 via HIF-1alpha and TGF-beta2 to promote chemoresistance in colorectal cancer.
    Proc Natl Acad Sci U S A. 2018 Jun 11. pii: 1801348115.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: